SCHEMBL24299972

SCHEMBL24299972

C#CCN(c1ccc(NS(=O)(=O)c2ccccc2C)c2ccccc12)[C@@H](C)CC(=O)OC

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KEAP1 Q14145 10/20 0.39
▸ NFE2L2 Q16236 4/20 0.39
▸ KMT2A Q03164 4/20 0.37
▸ MEN1 O00255 3/20 0.37
▸ GAA P10253 2/20 0.37
▸ G6PD P11413 1/20 0.37
▸ MAP1LC3B Q9GZQ8 1/20 0.37
▸ BRD4 O60885 2/20 0.37
▸ FPR1 P21462 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ TP53 P04637 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ PKM P14618 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ ALOX15 P16050 1/20 0.33
▸ CASP1 P29466 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22922680 0.91 KMT2A (0.50) KEAP1NFE2L2KMT2AMEN1GAA
SCHEMBL29540066 0.91 KMT2A (0.39) KEAP1NFE2L2KMT2AMEN1GAA
SCHEMBL22922526 0.91 KMT2A (0.39) KEAP1NFE2L2KMT2AMEN1GAA
SCHEMBL22922654 0.90 BRD4 (0.41) KEAP1NFE2L2KMT2AMEN1GAA
SCHEMBL26360877 0.88 MEN1 (0.39) KEAP1NFE2L2KMT2AMEN1GAA
SCHEMBL22922454 0.88 KEAP1 (0.48) KEAP1NFE2L2KMT2AGAAALDH1A1
SCHEMBL26357034 0.88 KEAP1 (0.47) KEAP1NFE2L2KMT2AMEN1MAP1LC3B
SCHEMBL26357069 0.88 KEAP1 (0.42) KEAP1NFE2L2KMT2AMEN1GAA
SCHEMBL26356901 0.87 KEAP1 (0.49) KEAP1NFE2L2GAAKDM4EALDH1A1
SCHEMBL22922540 0.86 KEAP1 (0.42) KEAP1NFE2L2KMT2AMEN1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11773057-B2 Naphthalenesulfonamide compound, preparation method, and application CHINA PHARMACEUTICAL UNIVERSITY (CN) 2023-10-03 — — US disclosed
US-11773057-B2 Naphthalenesulfonamide compound, preparation method, and application CHINA PHARMACEUTICAL UNIVERSITY (CN) 2023-10-03 — — US disclosed
EP-3978471-A1 NAPHTHALENESULFONAMIDE COMPOUND, PREPARATION METHOD, AND APPLICATION China Pharmaceutical University (CN) 2022-04-06 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11773057-B2 Naphthalenesulfonamide compound, preparation method, and application NFE2L2, KEAP1, NFE2 KEAP1 2/4885NFE2L2 1/4885KMT2A 2133/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback